We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

317 hedge funds and large institutions have $3.47B invested in Amedisys in 2019 Q1 according to their latest regulatory filings, with 64 funds opening new positions, 117 increasing their positions, 107 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 43

7% more funds holding

Funds holding: 297317 (+20)

9% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 107

2% more capital invested

Capital invested by funds: $3.41B → $3.47B (+$55.8M)

4.06% less ownership

Funds ownership: 92.17%88.11% (-4.1%)

61% less call options, than puts

Call options by funds: $10.3M | Put options by funds: $26.4M

Holders
317
Holders Change
+20
Holders Change %
+6.73%
% of All Funds
6.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
64
Increased
117
Reduced
107
Closed
43
Calls
$10.3M
Puts
$26.4M
Net Calls
-$16.1M
Net Calls Change
-$18M
Name Holding Trade Value Shares
Change
Change in
Stake
HSBC Holdings
101
HSBC Holdings
United Kingdom
$3.31M +$1.16M +9,252 +52%
FP
102
Foundry Partners
Minnesota
$3.2M -$538K -4,289 -14%
MOACM
103
Mutual of America Capital Management
New York
$3.16M +$3.13M +24,936 +3,435%
CIBC World Market
104
CIBC World Market
Ontario, Canada
$3.12M -$44.2K -352 -1%
CEP
105
Chicago Equity Partners
Illinois
$2.99M -$1.78M -14,205 -37%
Connor, Clark & Lunn Investment Management (CC&L)
106
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.86M +$1.94M +15,425 +198%
3C
107
361 Capital
Colorado
$2.81M +$246K +1,957 +9%
State of Tennessee, Department of Treasury
108
State of Tennessee, Department of Treasury
Tennessee
$2.7M -$377 -3 -0%
UBS AM
109
UBS AM
Illinois
$2.7M +$291K +2,322 +12%
Los Angeles Capital Management
110
Los Angeles Capital Management
California
$2.66M -$354K -2,820 -12%
MAM
111
Martingale Asset Management
Massachusetts
$2.66M -$176K -1,400 -6%
ASRS
112
Arizona State Retirement System
Arizona
$2.58M -$2.98M -23,773 -53%
TCM
113
Timpani Capital Management
Wisconsin
$2.57M +$1.41M +11,237 +117%
OPERF
114
Oregon Public Employees Retirement Fund
Oregon
$2.54M +$1.2M +9,575 +87%
SGH
115
Sivik Global Healthcare
Connecticut
$2.46M
Voloridge Investment Management
116
Voloridge Investment Management
Florida
$2.44M +$2.49M +19,809 New
NA
117
Navellier & Associates
Nevada
$2.44M +$279K +2,226 +13%
TPSF
118
Texas Permanent School Fund
Texas
$2.44M +$98.9K +788 +4%
Macquarie Group
119
Macquarie Group
Australia
$2.43M +$1.22M +9,700 +97%
PAM
120
Panagora Asset Management
Massachusetts
$2.43M -$14.7K -117 -0.6%
GC
121
Guggenheim Capital
Illinois
$2.42M +$509K +4,055 +26%
OAM
122
Oxford Asset Management
United Kingdom
$2.38M +$1.6M +12,728 +193%
VIA
123
Vident Investment Advisory
Georgia
$2.34M -$1.39M -11,114 -37%
HI
124
HBK Investments
Texas
$2.31M -$1M -7,991 -30%
MSL
125
Mackay Shields LLC
New York
$2.1M +$62.8K +500 +3%

AMED Hedge Fund Activity: Q1 2019 in Review

317 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2019, worth a combined $3.47B — up 1.6% from $3.41B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new AMED positions and 43 closed out — a net gain of 21 holders — while 117 added to existing stakes and 107 trimmed.

The largest buyer was Man Group, adding an estimated $22.4M. The largest seller was BlackRock, cutting an estimated $104M.

  • 317 institutional investors held Amedisys (AMED) as of Q1 2019, up from 297 in Q4 2018.
  • Funds reported $3.47B of Amedisys stock for Q1 2019, up 1.6% quarter-over-quarter.
  • 64 funds opened new Amedisys positions in Q1 2019 and 43 closed out, a net change of +21 holders.
  • The largest Amedisys buyer in Q1 2019 was Man Group, an estimated $22.4M added.
  • The largest Amedisys seller in Q1 2019 was BlackRock, an estimated $104M sold.

Based on aggregated 13F filings for Q1 2019.